Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 529

1.

CTLA-4+ Regulatory T Cells are Increased in Cetuximab Treated Head and Neck Cancer Patients, Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.

Jie HB, Schuler PJ, Lee SC, Srivastava RM, Argiris A, Ferrone S, Whiteside TL, Ferris RL.

Cancer Res. 2015 Apr 1. pii: canres.2788.2014. [Epub ahead of print]

PMID:
25832655
2.

Dendritic cell-based autologous tumor vaccines for head and neck squamous cell carcinoma: Promise vs reality.

Whiteside TL, Ferris RL, Szczepanski M, Tublin M, Kiss J, Johnson R, Johnson JT.

Head Neck. 2015 Mar 3. doi: 10.1002/hed.24025. [Epub ahead of print]

PMID:
25735641
3.

Chondroitin sulfate proteoglycan-4 (CSPG4)-specific monoclonal antibody 225.28 in detection of acute myeloid leukemia blasts.

Fenton M, Whiteside TL, Ferrone S, Boyiadzis M.

Oncol Res. 2015;22(2):117-21. doi: 10.3727/096504014X14174484758503.

PMID:
25706398
4.

Information transfer by exosomes: A new frontier in hematologic malignancies.

Boyiadzis M, Whiteside TL.

Blood Rev. 2015 Jan 30. pii: S0268-960X(15)00013-2. doi: 10.1016/j.blre.2015.01.004. [Epub ahead of print]

PMID:
25686749
5.

Classification of current anticancer immunotherapies.

Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G.

Oncotarget. 2014 Dec 30;5(24):12472-508.

6.

Clinical Impact of Regulatory T cells (Treg) in Cancer and HIV.

Whiteside TL.

Cancer Microenviron. 2014 Nov 12. [Epub ahead of print]

PMID:
25385463
7.

Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.

Szczepanski MJ, Luczak M, Olszewska E, Molinska-Glura M, Zagor M, Krzeski A, Skarzynski H, Misiak J, Dzaman K, Bilusiak M, Kopec T, Leszczynska M, Witmanowski H, Whiteside TL.

J Mol Med (Berl). 2015 Mar;93(3):305-14. doi: 10.1007/s00109-014-1217-3. Epub 2014 Nov 12.

8.

Biological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Therapy of Melanoma.

Spitler LE, Cao H, Piironen T, Whiteside TL, Weber RW, Cruickshank S.

Am J Clin Oncol. 2014 Oct 3. [Epub ahead of print]

PMID:
25286079
9.

Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia.

Hong CS, Muller L, Boyiadzis M, Whiteside TL.

PLoS One. 2014 Aug 5;9(8):e103310. doi: 10.1371/journal.pone.0103310. eCollection 2014.

10.

Isolation of biologically-active exosomes from human plasma.

Muller L, Hong CS, Stolz DB, Watkins SC, Whiteside TL.

J Immunol Methods. 2014 Sep;411:55-65. doi: 10.1016/j.jim.2014.06.007. Epub 2014 Jun 18.

PMID:
24952243
11.

Measurements of natural killer (NK) cells.

Butterfield LH, Whiteside TL.

Crit Rev Oncog. 2014;19(1-2):47-55. Review.

PMID:
24941372
12.

Induced regulatory T cells in inhibitory microenvironments created by cancer.

Whiteside TL.

Expert Opin Biol Ther. 2014 Oct;14(10):1411-25. doi: 10.1517/14712598.2014.927432. Epub 2014 Jun 17.

13.

Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas.

Pollack IF, Jakacki RI, Butterfield LH, Hamilton RL, Panigrahy A, Potter DM, Connelly AK, Dibridge SA, Whiteside TL, Okada H.

J Clin Oncol. 2014 Jul 1;32(19):2050-8. doi: 10.1200/JCO.2013.54.0526. Epub 2014 Jun 2.

PMID:
24888813
14.

Immunoregulatory activity of adenosine and its role in human cancer progression.

Muller-Haegele S, Muller L, Whiteside TL.

Expert Rev Clin Immunol. 2014 Jul;10(7):897-914. doi: 10.1586/1744666X.2014.915739. Epub 2014 May 29. Review.

PMID:
24871693
15.

Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia.

Hong CS, Muller L, Whiteside TL, Boyiadzis M.

Front Immunol. 2014 Apr 10;5:160. doi: 10.3389/fimmu.2014.00160. eCollection 2014.

16.

Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.

Schuler PJ, Saze Z, Hong CS, Muller L, Gillespie DG, Cheng D, Harasymczuk M, Mandapathil M, Lang S, Jackson EK, Whiteside TL.

Clin Exp Immunol. 2014 Aug;177(2):531-43. doi: 10.1111/cei.12354.

PMID:
24749746
17.

Phase I dendritic cell p53 peptide vaccine for head and neck cancer.

Schuler PJ, Harasymczuk M, Visus C, Deleo A, Trivedi S, Lei Y, Argiris A, Gooding W, Butterfield LH, Whiteside TL, Ferris RL.

Clin Cancer Res. 2014 May 1;20(9):2433-44. doi: 10.1158/1078-0432.CCR-13-2617. Epub 2014 Feb 28.

PMID:
24583792
18.

Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy.

Szajnik M, Derbis M, Lach M, Patalas P, Michalak M, Drzewiecka H, Szpurek D, Nowakowski A, Spaczynski M, Baranowski W, Whiteside TL.

Gynecol Obstet (Sunnyvale). 2013 Apr 29;Suppl 4:3.

19.

Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?

Whiteside TL.

Cancer Immunol Immunother. 2014 Jan;63(1):67-72. doi: 10.1007/s00262-013-1490-y. Epub 2013 Nov 10. Review.

20.

Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.

Jie HB, Gildener-Leapman N, Li J, Srivastava RM, Gibson SP, Whiteside TL, Ferris RL.

Br J Cancer. 2013 Nov 12;109(10):2629-35. doi: 10.1038/bjc.2013.645. Epub 2013 Oct 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk